Science AI Journal
Biochemistry, Genetics and Molecular Biology · Research topic

Open research questions in Endoplasmic Reticulum Stress and Disease

44 unresolved questions extracted from the limitations and future-work sections of 145 Endoplasmic Reticulum Stress and Disease papers in our library. Each links back to the study that raised it.

What the literature leaves open

  • EMT is accompanied by extensive remodeling of the secretory pathway, yet how cancer cells maintain endoplasmic reticulum (ER) homeostasis during this transition remains unclear.

    Epithelial-Mesenchymal Transition Induces FAM134A-mediated ER-phagy to Regulate Procollagen Secretion · 2026 · DOI

  • While biochemical studies confirm IRE1’s role in recognizing unfolded polypeptides, high-resolution structures showing direct interactions remain elusive.

    Structural dynamics of IRE1 and its interaction with unfolded peptides · 2026 · DOI

  • Although renal functional, histological injury, apoptosis, and ERS/UPR- associated protein readouts showed directionally consistent changes, treatment-effect estimates remain imprecise and should be validated in larger, prospectively powered large-animal studies. Second, the porcine experiment was limited by a modest final sample size.

    Integrated transcriptomics identifies ER stress–associated apoptosis in post-resuscitation AKI and supports early Dl-3-n-butylphthalide–associated renoprotection in a porcine TCA model · 2026 · DOI

  • Collectively, emerging evidence indicates that osteogenic therapeutic strategies targeting ER homeostasis are evolving from single-pathway interventions toward threshold-guided precision modulation frameworks tailored to pathological context and osteogenic stage (Wu et al., 2023). Coordinated modulation of local stress ER microenvironmental osteogenic stages—together with consideration of dose–duration-dependent ER homeostasis features—may provide more translationally feasible therapeutic routes for OP (Song et al., 2024; Martin and Bettencourt, 2018; Cha et al., 2016; Yang et al., 2020). ER-phagy at activity, defined attenuation, conditions regulatory and single interventions, and Nevertheless, several key limitations remain. ER stress signaling and bone metabolic regulation form highly interconnected networks with strong dose- and time-dependent functional outputs. However, current studies still predominantly focus on single-pathway modulation or lack time-point systematic characterization of actionable regulatory windows across pathological contexts and osteogenic differentiation stages, thereby limiting the predictability and controllability of therapeutic outcomes (Hetz and Papa, 2018). Moreover, most current evidence is derived from in vitro systems or acute animal models, which may not fully capture the long-term effects of ER homeostasis modulation on osteogenic outcomes under chronic metabolic dysregulation, aging, or inflammatory conditions (Zhong et al., 2023). To address these challenges, future investigations should prioritize two key directions. First, future studies should focus on the dynamic and systems-level characterization of ER homeostasis threshold properties and stage-dependent regulatory features in osteoblasts across different pathological contexts (Hetz and Papa, 2018; Zhong et al., 2023). Second, integration of single-cell and multi-omics approaches to define cell-type-specific ER homeostasis regulatory mechanisms and the cellular heterogeneity landscape across bone-related cell populations (Li et al., 2024). In this context, translating mechanistic insights into clinical applications represents an important direction for future research. Clinical studies examining the relationship between ER homeostasis and bone metabolism remain limited, with current evidence largely derived from small-sample clinical studies and correlational analyses, although these provide indirect support. For example, in patients with osteoporosis and metabolic bone diseases, elevated levels of ER stress–related markers (e.g., GRP78 and Frontiers in Cell and Developmental Biology 15 frontiersin.org Wang et al. 10.3389/fcell.2026.1809292 therapeutic potential CHOP) and oxidative stress indicators are associated with reduced bone mineral density and imbalanced bone turnover (Zhang P. et al., 2025). In addition, preclinical and translational studies suggest that interventions targeting UPR or protein-folding burden (e.g., in chemical chaperones) may have improving bone mass and microarchitecture (Al-Dagh et al., 2024). However, most existing evidence is based on crosssectional observations or animal-derived translational inferences, and there is a lack of large-scale, longitudinal clinical studies to establish the causal role of ER homeostasis in bone metabolism and its feasibility as a therapeutic target. Therefore, future studies are warranted to integrate clinical cohort analyses with multi-omics the clinical utility of ER approaches homeostasis–related biomarkers in osteoporosis risk assessment and treatment response prediction.

    Stage-dependent endoplasmic reticulum homeostasis in osteogenic differentiation · 2026 · DOI

  • adaptation. Furthermore, we discuss potential therapeutic strategies centered on restoration of ER homeostasis, aiming to provide an integrated framework bone regeneration therapy.

    Stage-dependent endoplasmic reticulum homeostasis in osteogenic differentiation · 2026 · DOI

  • The involvement of necroptosis through ER stress in microglia/macrophages after spinal cord injury has been identified, but the upstream triggers linking ER stress sensors (IRE1α, PERK, ATF6) to necroptotic effectors (RIPK1/RIPK3/MLKL) specifically in spinal cord-derived immune cells require mechanistic clarification.

    Endoplasmic reticulum stress-mediated cell death in spinal cord injury: from molecular mechanisms to therapeutic applications · 2026 · DOI

  • Multiple natural compounds (tetrahydrocurcumin, Panax quinquefolius saponin, melatonin) and engineered nanoparticles have shown promise in inhibiting ER stress-mediated pathways in spinal cord injury models, but direct comparative efficacy studies across these therapeutic agents in the same injury model and species are absent.

    Endoplasmic reticulum stress-mediated cell death in spinal cord injury: from molecular mechanisms to therapeutic applications · 2026 · DOI

  • The protective role of CHOP deletion in post-spinal cord injury microvasculature has been demonstrated in one study, but the mechanism by which CHOP-mediated apoptosis affects remote neuronal death through autophagosome overload remains incompletely characterized. The interplay between ER proteostasis restoration and selective autophagy flux in secondary injury zones needs direct investigation.

    Endoplasmic reticulum stress-mediated cell death in spinal cord injury: from molecular mechanisms to therapeutic applications · 2026 · DOI

  • While PERK-eIF2α-ATF4-CHOP signaling is established in various injury models including renal and pulmonary systems, the temporal dynamics and cell-type-specific activation of this pathway in acute versus chronic phases of spinal cord injury have not been systematically characterized with single-cell resolution.

    Endoplasmic reticulum stress-mediated cell death in spinal cord injury: from molecular mechanisms to therapeutic applications · 2026 · DOI

  • The IRE1α-XBP1 pathway's role in endoplasmic reticulum stress-mediated spinal cord injury has been demonstrated, but the specific contribution of XBP1 splicing versus its non-canonical functions remains unclear. Studies using hepatocyte-specific XBP1 deletion show hyperactivation of IRE1α, yet the translational relevance to spinal cord neurons and microglia/macrophages after traumatic injury has not been directly tested.

    Endoplasmic reticulum stress-mediated cell death in spinal cord injury: from molecular mechanisms to therapeutic applications · 2026 · DOI

  • The suppressed activity of the MGMT-mediated DNA damage reversal pathway in BM-MSCs under OP conditions and its role in accumulating DNA damage and triggering persistent unfolded protein response requires further mechanistic investigation.

    Identification of biomarkers associated with endoplasmic reticulum stress-related cell death in osteoporosis based on bulk and single-cell transcriptomic analyses and experimental validation · 2026 · DOI

  • While molecular docking indicated strong binding affinity between Danazol and DAPK3, functional studies are needed to confirm whether Danazol therapeutically targets DAPK3 and modulates the PERK–eIF2α–ATF4–CHOP and STING–IFN-β pathways in osteoporosis.

    Identification of biomarkers associated with endoplasmic reticulum stress-related cell death in osteoporosis based on bulk and single-cell transcriptomic analyses and experimental validation · 2026 · DOI

  • Pharmacodynamic monitoring incorporating p-eIF2α/ATF4-responsive signatures and resolution markers to define therapeutic windows and guide patient selection needs further development.

    Overcoming immunotherapy resistance in breast cancer: a novel strategy by targeting the integrated stress response · 2026 · DOI

  • Systemic targeting of PERK, GCN2, or downstream translation control carries predictable on-target risks including impaired stress tolerance in secretory tissues, altered metabolic adaptation, and unintended effects on immune-cell fitness, which require mitigation strategies.

    Overcoming immunotherapy resistance in breast cancer: a novel strategy by targeting the integrated stress response · 2026 · DOI

  • Artificial intelligence–assisted multi-omics platforms may enable extraction of ISR activity features from routine histopathological sections for noninvasive and dynamic monitoring, but development and optimization of such platforms are still needed.

    Overcoming immunotherapy resistance in breast cancer: a novel strategy by targeting the integrated stress response · 2026 · DOI

  • Biomarker-driven patient stratification is critical, with ongoing clinical trials evaluating phosphorylated eIF2α IHC scores, ISR-related gene signatures, and circulating exosomal ATF4 mRNA as predictive biomarkers, but validation and clinical implementation remain incomplete.

    Overcoming immunotherapy resistance in breast cancer: a novel strategy by targeting the integrated stress response · 2026 · DOI

  • Despite this knowledge, the complex interactions between these transcription factors and their coregulators has not been determined, and the mechanisms regulating UGT gene expression in organs and tissues, other than the liver, gastrointestinal tract, breast, and prostate, remain to be elucidated.

    The regulation of UDP-glucuronosyltransferase genes by tissue-specific and ligand-activated transcription factors · 2009 · DOI

  • While chronic, unresolved endoplasmic reticulum (ER) stress is known to compromise PDLSC stemness, the precise underlying mechanisms remain elusive.

    QRICH1 Disrupts Endoplasmic Reticulum Homeostasis and Amplifies NF‐κB Signaling in Periodontal Ligament Stem Cells to Exacerbate Diabetic Periodontitis · 2026 · DOI

  • NRF1 is a key mediator of the proteasome recovery pathway, yet its regulation by ER-resident factors is not fully elucidated.

    Cooperative regulation of NF-E2 related factor 1 protein stability and transcriptional activation by endoplasmic reticulum-associated degradation system mediator, Selenoprotein S/K. · 2026 · DOI

  • The pathway's inherent feedback loops and redundancy demand rational combination therapies that co-target multiple nodes to achieve durable responses, but optimal combinations have not been fully elucidated.

    Overcoming immunotherapy resistance in breast cancer: a novel strategy by targeting the integrated stress response · 2026 · DOI

  • Yet, surprisingly, mice bearing a disruption in the calreticulin gene die from a lesion in cardiac development and develop significant metabolic problems whereas calnexin-deficient mice are born alive with, yet not understood, neurological problems.

    Endoplasmic reticulum quality control and congenital pathology · 2005 · DOI

Most-cited papers in Endoplasmic Reticulum Stress and Disease

Most recent work

Find a gap in your own Endoplasmic Reticulum Stress and Disease sub-topic

This page shows what the Endoplasmic Reticulum Stress and Disease literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.

Open the Research Gap Finder →

Related topics in Biochemistry, Genetics and Molecular Biology

Gut microbiota and health
289 open questions
Single-cell and spatial transcriptomics
185 open questions
dental development and anomalies
121 open questions
Mitochondrial Function and Pathology
110 open questions
Genetic Associations and Epidemiology
106 open questions
Human-Animal Interaction Studies
105 open questions
Genomics and Chromatin Dynamics
97 open questions
Inflammatory Bowel Disease
91 open questions
44 open questions have been extracted from the limitations and future-work passages of 145 Endoplasmic Reticulum Stress and Disease papers in our library. Each one below links back to the study that raised it, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 120,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? A Tier 1–5 acceptance probability in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck prior-publication & salami-slicing risk across 8 sources.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.